What is the price targets for Cron stock?
The high price target for CRON is $30.00 and the low price target for CRON is $12.00. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold.".
Who sold Cron stock in the last quarter?
CRON stock was sold by a variety of institutional investors in the last quarter, including Connor Clark & Lunn Investment Management Ltd., TD Asset Management Inc., Citadel Advisors LLC, Susquehanna International Group LLP, Simplex Trading LLC, Raymond James Financial Services Advisors Inc.
Do analysts like Cronos Group (Cron) stock?
Analysts like Cronos Group stock less than the stock of other Medical companies. The consensus rating for Cronos Group is Hold while the average consensus rating for medical companies is Buy. Learn more
Is Cron stock trending positive or negative on Wednesday?
News headlines about CRON stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources.
See more
Is CRON a good stock?
CRON has a Quality Grade of F, ranking ahead of 0.86% of graded US stocks.
What is the future of CRON stock?
Stock Price Forecast The 12 analysts offering 12-month price forecasts for Cronos Group Inc have a median target of 3.92, with a high estimate of 8.45 and a low estimate of 2.96. The median estimate represents a +35.21% increase from the last price of 2.90.
Is CRON a good buy right now?
Today CRON ranks #16015 as sell candidate. Get $10 when you deposit $100* in your eToro account.
What sector is CRON stock?
Description. Cronos Group Inc. operates as a cannabinoid company.
Is CRON a good stock to buy 2021?
There's potential for Cronos stock to soar if its cultivated products prove to be the difference-makers that management expects them to be. But for now, this pot stock remains an ultra-risky buy.
What is the outlook for canopy growth?
The 15 analysts offering 12-month price forecasts for Canopy Growth Corp have a median target of 3.92, with a high estimate of 7.05 and a low estimate of 1.99. The median estimate represents a +8.85% increase from the last price of 3.60.
Is CGC a buy or sell?
The consensus among 7 Wall Street analysts covering (NASDAQ: CGC) stock is to Sell CGC stock.
Is ACB a buy or sell?
Today ACB ranks #18107 as sell candidate.
Is ReWalk robotics a good stock to buy?
ReWalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
How much cash does Cron have?
Compare CRON With Other StocksCronos Group Annual Cash on Hand (Millions of US $)2020$1,2902019$1,5062018$242017$72 more rows
What does Cronos Group do?
Cronos Group is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio.
Why did Cronos stock go up today?
Shares of global cannabis company Cronos Group (CRON -0.64%) rocketed higher on Tuesday after the company reported its earnings for the first three months of 2022. The company missed Wall Street's earnings per share (EPS) estimates, but investors were happy with its solid growth numbers.
Should I buy or sell Cronos Group stock right now?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 sel...
What is Cronos Group's stock price forecast for 2022?
8 Wall Street analysts have issued twelve-month target prices for Cronos Group's stock. Their forecasts range from $3.00 to $6.00. On average, they...
How has Cronos Group's stock price performed in 2022?
Cronos Group's stock was trading at $3.92 on January 1st, 2022. Since then, CRON shares have decreased by 30.4% and is now trading at $2.73. View...
When is Cronos Group's next earnings date?
Cronos Group is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Cronos Gr...
How were Cronos Group's earnings last quarter?
Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Tuesday, May, 10th. The company reported ($0.09) EPS for the quarter, missing analys...
Who are Cronos Group's key executives?
Cronos Group's management team includes the following people: Mr. Michael Ryan Gorenstein J.D. , Pres, CEO & Chairman (Age 35, Pay $389.15k) ( L...
Who are some of Cronos Group's key competitors?
Some companies that are related to Cronos Group include Tilray (TLRY) , Canopy Growth (CGC) , USANA Health Sciences (USNA) , Cresco Labs (CRLBF...
What other stocks do shareholders of Cronos Group own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC) , Aurora Cannab...
What is Cronos Group's stock symbol?
Cronos Group trades on the NASDAQ under the ticker symbol "CRON."
Is Cronos stock a Buy, Sell or Hold?
Cronos stock has received a consensus rating of hold. The average rating score is and is based on 0 buy ratings, 3 hold ratings, and 2 sell ratings.
What was the 52-week low for Cronos stock?
The low in the last 52 weeks of Cronos stock was 2.80. According to the current price, Cronos is 108.21% away from the 52-week low.
What was the 52-week high for Cronos stock?
The high in the last 52 weeks of Cronos stock was 9.42. According to the current price, Cronos is 32.17% away from the 52-week high.
What are analysts forecasts for Cronos stock?
The 5 analysts offering price forecasts for Cronos have a median target of 4.00, with a high estimate of 5.50 and a low estimate of 3.00. The media...
About Cronos Group
Cronos Group (NASDAQ:CRON) Frequently Asked Questions
Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
Signals & Forecast
7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 4 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Cronos Group stock.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, January 27, 2022, and so far it has risen 2.12%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Is Cronos Group Inc stock A Buy?
Cronos Group Inc finds support from accumulated volume at $3.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are positive buying more shares than they are selling in Cronos Group Inc
Cronos Group Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Golden Star Signal
In the last 95 trades there were 22.82 million shares bought and 16.11 million shares sold. The last trade was done 110 days ago by Shum Xiu Ming who sold 19.38 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Cronos Group Inc. (CRON) Q3 2021 Earnings Call Transcript
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Cronos Group net income falls, launches cost-cutting measures
At this time, I would like to turn the call over to Shayne Laidlaw, investor relations. Thank you, Catherine, and thank you for joining us today to review Cronos Group's 2021 third quarter financial and business performance. Today, I am joined by our president and CEO, Kurt Schmidt; our CFO, Bob Madore; and our executive chairman, Mike Gorenstein.
Cronos Group (NASDAQ:CRON) Price Target and Consensus Rating
Cronos Group said Friday its third-quarter net income fell to $55.1 million, or 21 cents a share, from $95.2 million, or 18 cents a share, in the year-ago period. The latest quarter includes a $132.9 million gain on revaluation of derivative liabilities.
Analyst Ratings By Month
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Cronos Group (NASDAQ:CRON) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
Cronos Group (CRON)
According to the issued ratings of 5 analysts in the last year, the consensus rating for Cronos Group stock is Hold based on the current 2 sell ratings, 2 hold ratings and 1 buy rating for CRON. The average twelve-month price target for Cronos Group is $8.05 with a high price target of $14.00 and a low price target of $3.24.
Cronos Group Inc. - Sell
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Style Scorecard
Zacks' proprietary data indicates that Cronos Group Inc. is currently rated as a Zacks Rank 4 and we are expecting a below average return from the CRON shares relative to the market in the next few months. In addition, Cronos Group Inc.
Chart for CRON
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
